FDA approves Teva's generic version of AstraZeneca's Nexium
Jan 26 (Reuters) - The U.S. Food and Drug Administration said it approved Teva Pharmaceutical Industries Ltd's generic version of AstraZeneca Plc (NYSE: AZN - news) 's Nexium to treat acid reflux, the agency's first generic approval for the drug.
Nexium, known chemically as esomeprazole, is used to reduce acid in the stomach. (http://1.usa.gov/1LbUqSL) (Reporting by Natalie Grover in Bengaluru; Editing by Ted Kerr)